Dr. Scott Simpson Eugene Merritt, MD

Dr. Merritt practices at West Central Gastroenterology in Zephyrhills, Florida.

Dr. Merritt's NPI, 1255596508, was assigned on July 25, 2008. Dr. Merritt graduated from Saba University School of Medicine in 2007. Dr. Merritt holds Florida license ME115789.

Dr. Merritt's primary practice is West Central Gastroenterology, at 37908 Daughtery Rd, Zephyrhills, FL 33541 in Pasco County. The practice phone is (727) 347-0005.

Dr. Merritt's primary practice is West Central Gastroenterology in Zephyrhills, Florida. The medical group on file is AdventHealth Medical Group Cardiovascular Surgery at Tampa. Dmand AI also links Dr. Merritt to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merritt practices. Vendor and product names are available with a free account.

Pediatrics is Dr. Merritt's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dmand AI has Dr. Merritt's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, anemia, cardiac arrhythmia, chest pain, congestive heart failure and gastrointestinal bleeding among the conditions Dr. Merritt treats.

CMS data shows 72 Medicare services from Dr. Merritt across 2 procedure codes in 2024, for 34 Medicare patients. Medicare paid $3,310 for them. Every service was in an office.

CMS counts 34 Medicare patients who saw Dr. Merritt in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merritt's median patient age at 72, with 57% women.

In 2024, Dr. Merritt wrote 7,711 Medicare Part D claims for 738 patients. 86% of them were for generic drugs. CMS names the drug for 6,947 of them, across 140 drugs with 11 or more claims each, at $470,929 in total drug cost. In 2023, CMS named 670 claims across 33 drugs.

Dr. Merritt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 47 general payments to Dr. Merritt from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $185.

Dr. Merritt graduated from Saba University School of Medicine in 2007.

Dr. Merritt is in network with 14 carriers, including United Healthcare, Cigna and Elevance. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.